Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Apr 2018 for Oncotelic Therapeutics, Inc..
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William D. Schwieterman: trading record in brief
This profile gathers the share dealings of William D. Schwieterman across 2 companies, led by Oncotelic Therapeutics, Inc. and Chelsea Therapeutics International, Ltd. Over a trading history stretching from 27 June 2007 to 12 April 2018, the count stands at 33 filings.
On the market, this insider has only ever bought: 6 purchases, €349k in total. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 17 share grants and 8 option exercises. Since January 2018: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €39k.
Most recently, on 16 April 2018, the filings show an open-market purchase in Oncotelic Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William D. Schwieterman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
625,000 sharesCommon StockSEC:0001209191-18-024989:0
Canonical exit: 11 Jul 2018 (T+90)
130,592 sharesCommon StockSEC:0001144204-14-039637:0
35,000 shares@ US$5.07Common StockSEC:0001144204-14-039637:1
50,000 shares@ US$4.65Common StockSEC:0001144204-14-039637:2
50,000 shares@ US$4.54Common StockSEC:0001144204-14-039637:3
10,000 shares@ US$2.96Common StockSEC:0001144204-14-039637:4
75,000 shares@ US$2.82Common StockSEC:0001144204-14-039637:5
30,000 shares@ US$1.78Common StockSEC:0001144204-14-039637:6
50,000 shares@ US$1.24Common StockSEC:0001144204-14-039637:7
50,000 shares@ US$0.96Common StockSEC:0001144204-14-039637:8
350,000 sharesCommon StockSEC:0001144204-14-039637:9
45,141 shares@ US$4.46Common StockSEC:0001181431-11-057715:0
Canonical exit: 21 Feb 2012 (T+90)
40,000 shares@ US$3.96Common StockSEC:0001181431-11-016796:0
Canonical exit: 5 Jun 2011 (T+90)
7,017 shares@ US$1.14Common Stock, $0.01 par value per shareSEC:0001181431-10-000806:0
3,169 shares@ US$1.42Common Stock, $0.01 par value per shareSEC:0001181431-09-046601:0
1,153 shares@ US$0.65Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:0
1,209 shares@ US$0.62Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:1
1,086 shares@ US$0.69Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:2
5,514 shares@ US$0.68Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:3
961 shares@ US$0.78Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:4
914 shares@ US$0.82Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:5
806 shares@ US$0.93Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:6
336 shares@ US$2.23Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:7
323 shares@ US$2.32Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:8
1,720 shares@ US$2.18Common Stock, $0.01 par value per shareSEC:0001181431-09-044443:9
25 of 29 declarations
